In accordance with this study, other groups have shown that increased levels of CRP in the blood are associated with poor clinical outcome in advanced inoperable esophageal cancer38 and in pancreatic cancer.39, 40, 41. This evidence concerns the gene CRP and familial pancreatic carcinoma.